P&G China's e-commerce business is growing at 60%, with seven of 10 categories holding or growing online market share, the firm’s Chinese e-commerce head says. Its global personal health care segment struggled in its latest quarter due to lower levels of product innovation compared to year-ago period.
China's bourgeoning e-commerce helped drive 7% sales growth there for Procter & Gamble Co.’s Crest, Oral-B and other oral care brands in its latest quarter, reflecting the firm's growing reliance on digital platforms for growth across its product categories.
Jasmine Xu, P&G's vice president for greater China e-business and branding, said during P&G’s fiscal 2018 first-quarter earnings briefing on...
Developments in India and Pakistan are designed to standardize how drug companies disclose their expenses associated with health care professionals.
AbbVie’s migraine ad overstates the drug’s benefit, a problem that is amplified by using a celebrity, the agency says.
The lung cancer drug Krazati from Bristol Myers Squibb’s Mirati Therapeutics drew an FDA ad/promo untitled letter, highlighting the agency's trend of pursuing false or misleading efficacy claims, particularly when data comes from outside approved labeling.
The UK and EU pharma industry associations have defended their respective codes of practice despite alarming study results. Meanwhile, a consultation on proposals to revise the UK code received over 3,500 comments.
Joint clinical assessment reports must be descriptive rather than reach definitive conclusions, and must not interfere with national decision making processes, according to new EU guidance.
Developments in India and Pakistan are designed to standardize how drug companies disclose their expenses associated with health care professionals.
The agency’s plan for advanced manufacturing seeks more harmonization, while also seeking to codify internal practices with guidance and training.
